U.S. Physical Therapy, Inc. USPH

NYSEHealth ServicesUnited States

$99.60+1.00 (+1.01%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 96.39100.27
52-week range: 58.19101.80

Financial health

– / 5

Analyst view · 7 firms

Buy6 buy · 1 hold · 0 sell

Avg. target $111.50 (+11.9%)

Prices may be delayed and are for informational purposes only - not investment advice.

U.S. Physical Therapy, Inc. USPH

NYSEHealth ServicesUnited States

$99.60+1.00 (+1.01%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 96.39100.27
52-week range: 58.19101.80

Financial health

– / 5

Analyst view · 7 firms

Buy6 buy · 1 hold · 0 sell

Avg. target $111.50 (+11.9%)

Valuation from filings

Calculated from the tables below and the current price ($99.60) · LTM · 2026/9 · 2026-09-30

P/E: —EPS $-1.34
P/B: 3.49BV/share $28.52
P/S: 1.79Sales/share $55.64
Return on equity: 7.0%Net income / equity
Net margin: 3.6%Operating margin 9.1%
Free cash flow yield: 4.6%Free cash flow / market cap

Revenue and net income

Fiscal year · $ millions · net margin below

RevenueNet Income

Financial statements

$ thousands · Under each value: change against a year earlier

Upgrade to MakklerPRO to see every row.Upgrade to MakklerPRO

Fiscal year	2021	2022	2023	2024	2025	LTM
Income Statement
Revenue	495,022	553,144+12%	604,802+9%	671,345+11%	780,990+16%	837,628
Gross Profit
Operating expenses
Operating Income
EBITDA
Pre-tax income
Income tax (expense) / benefit
Net Income	40,831	32,158-21%	28,239-12%	31,424+11%	39,583+26%	30,134
Earnings per share ($)
Margins
Gross margin
Operating margin
EBITDA margin
Net margin

Taken from the company's own 10-K and 10-Q filings via the SEC's XBRL data service. The "LTM" column is the last completed fiscal year plus the current year to date, minus the same period a year earlier. Lines a company tags with a non-standard label are left blank rather than filled with an approximation. Not investment advice.